BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Phenobarbital, rs2476601, BRCA1, Response to oxidative stress, Breast Cancer, Breast)
Bookmark Forward

QuickView for TRPV4 (gene)


Body Atlas

Most Correlated Tissues

  1. Rectum colon
  2. Ascending colon
  3. Transverse colon
  4. Granulocyte-macrophage progenitor cell of bone marrow
  5. Sigmoid colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Sensorineural hearing loss
  2. Muscle atrophy
  3. Brachydactyly
  4. Motor neuron disease
  5. Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. HX 630
  2. Cetirizine
  3. Catechin
  4. Sulfamerazine
  5. Connective Tissue Growth Factor
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ORAI1
  2. PTH
  3. PRL
  4. ARRB2
  5. MIR29B2CHG
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Involvement of TRPV4 in temperature-dependent perspiration in mice.
  2. Electroacupuncture ameliorates neuroinflammation by inhibiting TRPV4 channel in ischemic stroke.
  3. Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary a…
  4. Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates Seizures.
  5. TRPV4 mediates IL-1-induced Ca2+ signaling, ERK activation and MMP expression.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. The Natural History of TRPV4 Neuropathy
  2. A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Block…
  3. A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Coug…
  4. A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Fa…
  5. Salt Sensitivity Hypertension and Lens Opacities
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.